TRAF4 is a critical molecule for Akt activation in lung cancer

Wei Li1, Cong Peng, Mee-Hyun Lee

  • 1Authors' Affiliations: The Hormel Institute, University of Minnesota, Austin, Minnesota; Cancer Research Institute, Xiangya School of Medicine; Xiangya Hospital, Central South University, Changsha, Hunan; The First Affiliated Hospital; and Physiology and Pathophysiology, Basic Medical School, Zhengzhou University, Zhengzhou, Henan, China.

Cancer Research
|October 25, 2013
PubMed

Insights

Tumorigenesis involves the adapter protein TRAF4 (TNF receptor associated factor 4), which is overexpressed in lung cancer. TRAF4 activates Akt kinase, promoting cancer cell survival and growth, suggesting it as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Tumor necrosis factor receptor associated factor 4 (TRAF4) is an adapter protein implicated in various cancers.
  • Its specific role in lung tumorigenesis and its molecular mechanisms remain largely unelucidated.

Purpose of the Study:

  • To investigate the role of TRAF4 in lung cancer development and progression.
  • To elucidate the molecular pathways through which TRAF4 influences cancer cell phenotypes.

Main Methods:

  • Utilized RNA interference to attenuate TRAF4 expression in lung cancer cells.
  • Assessed effects on cell proliferation, anchorage-independent growth, and tumor development in a xenograft mouse model.
  • Investigated TRAF4's role in Akt kinase activation and glucose metabolism regulators (Glut1, HK2).

Main Results:

  • TRAF4 is overexpressed in lung cancer cells and primary tumors.
  • TRAF4 depletion significantly inhibited cancer cell proliferation, anchorage-independent growth, and tumor formation in vivo.
  • TRAF4, independent of Skp2, was essential for Akt kinase activation via ubiquitination.
  • TRAF4 attenuation impaired glucose metabolism by downregulating Akt-mediated Glut1 and HK2 expression.

Conclusions:

  • TRAF4 plays a critical role in promoting lung cancer cell proliferation, survival, and tumor development.
  • TRAF4's mechanism involves the activation of the Akt signaling pathway, impacting glucose metabolism.
  • TRAF4 represents a potential molecular target for novel lung cancer therapies.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
64.7K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
4.4K